Literature DB >> 35428922

Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis.

Lei Huang1, Chi Fu2, Jie Li2, Shijun Peng2.   

Abstract

BACKGROUND: Patients with dementia have higher risk of epilepsy. However, it remains not comprehensively evaluated if late-onset epilepsy (LOE) is associated with higher risk of dementia. We, therefore, performed a meta-analysis to systematically evaluate the association.
METHODS: Relevant cohort studies were identified by search of electronic databases including PubMed, Embase, and Web of Science. A randomized-effect model incorporating the possible between-study heterogeneity was used to pool the results.
RESULTS: Overall, seven cohort studies including 873,438 adults were included, and 16,036 (1.8%) of them had LOE. With a mean follow-up duration of 8.7 years, 33,727 of them were diagnosed as dementia. Pooled results showed that LOE was associated with a higher risk of dementia (risk ratio [RR] 2.39, 95% confidence interval [CI] 2.04-2.81, p < 0.001, I2 = 67%). Results of subgroup analysis showed that the association between LOE and the risk of dementia was stronger in hospital-derived participants (RR 4.23, 95% CI 2.67-6.70, p < 0.001) than that in community-derived population (RR 2.25, 95% CI 1.93-2.63, p < 0.001; p for subgroup difference = 0.01). Pooled results of three studies showed that LOE was associated with a higher risk of Alzheimer's disease (RR 2.35, 95% CI 1.08-5.08, p = 0.03, I2 = 85%). One study suggested a significant association between LOE and risk of vascular dementia (RR 2.0, 95% CI 1.77-2.26, p < 0.001).
CONCLUSIONS: Evidence from cohort studies suggests that LOE may be a risk factor of dementia.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alzheimer’s disease; Cohort; Dementia; Late-onset epilepsy; Meta-analysis

Mesh:

Year:  2022        PMID: 35428922     DOI: 10.1007/s40520-022-02118-8

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   4.481


  36 in total

1.  Pharmacotherapeutic considerations for late-onset epilepsy.

Authors:  Francesco Brigo; Simona Lattanzi
Journal:  Expert Opin Pharmacother       Date:  2020-12-30       Impact factor: 3.889

Review 2.  Late-onset unexplained epilepsy: What are we missing?

Authors:  Rani A Sarkis; Kim C Willment; Page B Pennell; Gad Marshall
Journal:  Epilepsy Behav       Date:  2019-08-31       Impact factor: 2.937

Review 3.  Late-onset seizures and risk of subsequent stroke: a systematic review.

Authors:  Francesco Brigo; Frediano Tezzon; Raffaele Nardone
Journal:  Epilepsy Behav       Date:  2013-11-26       Impact factor: 2.937

Review 4.  Idiopathic generalized epilepsy of late onset.

Authors:  J Loiseau; A Crespel; M C Picot; B Duché; N Ayrivié; P Jallon; P Loiseau
Journal:  Seizure       Date:  1998-12       Impact factor: 3.184

Review 5.  Late-onset epilepsy.

Authors:  M Hildick-Smith
Journal:  Br J Clin Pract       Date:  1994 Mar-Apr

Review 6.  Late-onset epilepsy and occult cerebrovascular disease.

Authors:  Lorna M Gibson; Martha F Hanby; Sarah M Al-Bachari; Laura M Parkes; Stuart M Allan; Hedley C A Emsley
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

7.  Epilepsy and aging.

Authors:  Robert J Kotloski; Jessie Dowding; Bruce P Hermann; Thomas P Sutula
Journal:  Handb Clin Neurol       Date:  2019

8.  Occult cerebrovascular disease and late-onset epilepsy: could loss of neurovascular unit integrity be a viable model?

Authors:  Lorna M Gibson; Stuart M Allan; Laura M Parkes; Hedley C A Emsley
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-03-06

Review 9.  Cognition and dementia in older patients with epilepsy.

Authors:  Arjune Sen; Valentina Capelli; Masud Husain
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

10.  Structural and physiological MRI correlates of occult cerebrovascular disease in late-onset epilepsy.

Authors:  Martha F Hanby; Sarah Al-Bachari; Fadiyah Makin; Rishma Vidyasagar; Laura M Parkes; Hedley C A Emsley
Journal:  Neuroimage Clin       Date:  2015-08-20       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.